Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 6,000 shares at $22.95 ($138K) on 2026-06-29, disclosed to the SEC on 2026-06-30.
Scheduled sale ($138k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GLUE | SELL | 2026-02-24 | $179K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |